News

A few days ago, Julio Ríos, director of INiBICA, shared the excitement surrounding the official accreditation from the Carlos III Health Institute, which recognizes INiBICA as a Health Research Center. 🗣️ Ríos emphasized that “What this accreditation confirms is that INiBICA meets the highest standards in terms of governance, transparency, management, scientific strategy, our capabilities, output…and most importantly, our impact on the Cadiz community.” “We have met more than 95% of these criteria, and we have been recognized for our ability—from southern Europe—to generate knowledge and improve the healthcare system.” He also emphasized that “the public is increasingly understanding how we are able to improve research and healthcare.” 💙 Thank you to Onda Cádiz for providing this platform and allowing us to continue building science from the local level. 🎥 Listen to the full interview starting at the 16-minute mark at the following link 🔗 More information: Instagram

🌟 A new recognition from ITEMAS—ISCIII —for the QUIRUCOMP project, which develops carbon-fiber surgical instruments, prompted a visit by physicians from the HUPM , and researchers from INiBICA to the CFA at Puerto Real to work on consolidating industrial scaling. 🤝 The meeting aimed to strengthen ties between the biomedical sector and Cádiz’s cutting-edge industry to advance the QUIRUCOMP project, which stems from a collaboration between Titania, INiBICA, and the UCA, funded by the CTA, following the project’s success in the “Pitch Competition” organized by the ITEMAS Platform at ISCIII. At that event, QUIRUCOMP was selected as one of three winning initiatives out of 13 finalists from across Spain, in recognition of its high potential for commercialization and its impact on patients. ⚙️ QUIRUCOMP, led by Dr. Pablo Andrés Cano—a Specialist in Traumatology and Osteoarticular Surgery and Principal Investigator of INiBICA’s emerging EM12 group—aims to revolutionize medical instruments by replacing steel with composite materials such as carbon fiber. This allows for the creation of customized, radiolucent, lighter, and more ergonomic instruments, reducing surgeon fatigue and improving intraoperative precision for safer and more efficient surgeries. 📍 During the event, the INiBICA delegation was welcomed by Francisco Javier Romalde Quintana, Operations Manager at FIDAMC at the CFA. Also in attendance were Dr. Borja Sanz, FEA in Neurosurgery and a researcher with INiBICA’s established CO5 research group, and Paula Castro, a technician from INiBICA’s Office of Innovation and Knowledge Transfer, who is responsible for managing the commercialization of these results. The visit served to explore the capabilities of the CFA’s state-of-the-art machinery, which is key to the validation and future manufacturing of these medical devices. 🔗 More information: Instagram

INiBICA opens the door to your future with the ✍️ Expression of Interest for the AES 2026 HR job openings: iPFIS Juan Rodés Sara Borrell Miguel Servet Bioinformatics Technician at the IIS Health Research Coordinator at the IIS 🌟 These grants offer a unique opportunity to join c Projects , surrounded by multidisciplinary teams and with access to cutting-edge infrastructure. 🔬 If you’re looking to grow professionally, make an impact in healthcare, and be part of an accredited institute committed to talent, now is your chance 👩‍🔬👨‍🔬 🤝 At INiBICA, you’ll not only find a stimulating work environment but also an opportunity to enjoy the province of Cádiz ☀️ 💼 Submit your expression of interest and take the first step toward a career that transforms lives! Send your resume, indicating the position you’re interested in the subject line, to 📩 info@inibica.es 🔗 More information: Instagram

El Instituto de Salud Carlos III, dependiente del Ministerio de Ciencia, Innovación y Universidades, concede este reconocimiento al organismo del que forma parte la Universidad de Cádiz   El Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA) ha obtenido la acreditación como Instituto de Investigación Sanitaria (IIS) concedida por el Instituto de Salud Carlos III, organismo dependiente del Ministerio de Ciencia, Innovación y Universidades. Este reconocimiento valida la calidad científica, la gobernanza y el impacto en salud del instituto, y sitúa a Cádiz junto a Sevilla, Córdoba, Málaga y Granada en la red de institutos biomédicos acreditados de Andalucía. Un hito histórico para la Universidad de Cádiz y la provincia  La Universidad de Cádiz (UCA) celebra el reconocimiento oficial al INiBICA como Instituto de Investigación Sanitaria, un sello de excelencia que acredita la solidez científica y la capacidad de transferencia del conocimiento desde el laboratorio hasta el paciente. Para la UCA, este logro supone un impulso estratégico a toda la investigación sanitaria en la provincia, donde la universidad desempeña un papel tractor en el ecosistema biomédico del sur de Europa. “La acreditación del INiBICA constituye un hito histórico para la Universidad de Cádiz y para toda la provincia. Supone un respaldo muy valioso a la excelencia y al compromiso de los investigadores que integran el instituto y abre una nueva etapa de mayor proyección científica y capacidad transformadora”, ha señalado Casimiro Mantell, rector de la UCA. Quiénes integran y gestionan el INiBICA El INiBICA es un referente de I+D+i biomédica gestionado por la Fundación para la Gestión de la Investigación Biomédica de Cádiz, con la participación activa de: Universidad de Cádiz (UCA) Consejería de Universidad, Investigación e Innovación Servicio Andaluz de Salud Consejería de Sanidad, Presidencia y Emergencias Esta acreditación incorpora al INiBICA al grupo selecto de centros sanitarios de investigación reconocidos a nivel nacional, reforzando el posicionamiento de la UCA como agente clave del conocimiento biomédico en Andalucía y el sur de Europa. Dimensión investigadora: proyectos, grupos y producción científica La comunidad investigadora de la UCA ha sido determinante en este logro colectivo. En la actualidad, el INiBICA cuenta con: Más de 60 proyectos nacionales e internacionales activos 200 ensayos y estudios clínicos en áreas prioritarias de salud Más de 60 grupos de investigación divididos en: 31 grupos consolidados, 15 emergentes y 15 asociados Bajo la dirección científica de Manuel Aguilar, la producción del instituto en los últimos cinco años supera: 2.000 publicaciones académicas 30 guías de práctica clínica Más de 70 solicitudes de patentes y registros de propiedad intelectual Estos indicadores reflejan una alta capacidad de transferencia del conocimiento y de impacto en la atención sanitaria. “Esta acreditación reconoce la labor de investigación en Ciencias de la Salud impulsada y sostenida desde el ámbito sanitario y universitario. Es el resultado de un trabajo conjunto iniciado hace años… Detrás de esta acreditación hay muchas personas y equipos mixtos que han trabajado de manera coordinada”, ha destacado Isabel Benavente, vicerrectora de Ciencias de la Salud y Bienestar de la Comunidad Universitaria. Cádiz se suma a la red andaluza de IIS acreditados por el Carlos III Con esta resolución, Cádiz se suma oficialmente a los institutos de investigación biomédica de Andalucía vinculados a la sanidad pública ya acreditados por el Instituto de Salud Carlos III: Sevilla, Córdoba, Málaga y Granada. El movimiento refuerza la colaboración entre universidad y sistema sanitario público y consolida un modelo de investigación traslacional orientado a la mejora de la salud de la ciudadanía. Compromiso institucional y próxima etapa Para la Universidad de Cádiz, esta acreditación no es solo un respaldo al esfuerzo investigador, sino una confirmación de su compromiso con: La investigación de impacto social La colaboración universidad–sanidad pública La innovación como motor de progreso económico y bienestar ciudadano El INiBICA seguirá integrando investigación básica, traslacional y clínica bajo un marco estratégico de sostenibilidad científica, con el objetivo de seguir apoyando el talento científico y la innovación biomédica al servicio de la salud

We’re celebrating! INiBICA is now an institute accredited by the Carlos III Health Institute, an agency under the Ministry of Science, Innovation, and Universities 🏅 This seal of excellence marks a milestone for biomedical research and attests to the institute’s scientific quality, the strength of its governance, and its direct impact on public health. It provides a strategic boost to all health research conducted in the province of Cádiz, offers invaluable support for the commitment of the institute’s researchers, and ushers in a new era of greater scientific influence and transformative capacity. 👨‍🔬👩‍🔬 Behind this accreditation are many individuals and interdisciplinary teams who have worked in a coordinated manner for years, and we thank them for this shared effort. 🔬 This accreditation places our institute among the select group of nationally recognized biomedical research centers, and Cádiz officially joins the other biomedical research institutes in Andalusia linked to the public health system and accredited by the Carlos III Health Institute, such as those in Seville, Córdoba, Málaga, and Granada. 📸 Present during the official announcement were INiBiCA’s Governing Council, the Scientific Directorate, its various departments, and the Executive Management; the rector of the University of Cádiz; the Government Delegate in Cádiz ; and the Regional Health Delegate. Representatives from the Board of Trustees of the Biomedical Foundation Cádiz also participated. 🔗 More information: Diario de Cádiz || UCA || Instagram

👩‍⚕️👨‍⚕️ From December 3 to 5, 2025, the Hospital Hospital Universitario Puerta del Mar (Cádiz) will host the Advanced Course in Laparoscopy and Hysteroscopy – Tips & Tricks, a training program designed for residents ( R3–R4) and junior attending physicians in gynecology, focused on refining advanced surgical techniques. Endorsed by SEGO and the Endoscopy Section, this course offers a theoretical and practical approach featuring live surgery, simulator exercises, sessions on surgical complications, and a certified final assessment. Key topics include: Laparoscopy for benign conditions, endometriosis, and pelvic floor disorders; advanced techniques in gynecologic oncology; Outpatient hysteroscopy and management of complex cases. Robotic surgery, V-NOTES, and advanced laparoscopic suturing. Practical assessment of laparoscopic skills (GESEA). With a maximum capacity of 60 participants, the course guarantees a personalized learning experience, with direct supervision by specialists and a hands-on approach aimed at consolidating high-level surgical skills. You can view the detailed program 👉 HERE. If you’d like to participate in this advanced training, you can register via the following 👉 link. This course is a unique opportunity to improve your surgical skills, update your knowledge, and learn from leading professionals in endoscopic gynecology. 🌟 Don’t miss the chance to join this intensive training experience. Sign up and participate!

On January 29 and 30, 2026, the School of Medicine at the University of Cádiz will host the new Congress of the Andalusian Society of Pediatric Endocrinology (SAEP) 🧬🩺 The event will feature a comprehensive program including scientific lectures, oral presentations, roundtable discussions on clinical trials, and a session dedicated to the history of pediatric endocrinology in Andalusia. Highlighted topics will include presymptomatic type 1 diabetes (DM1), childhood obesity, hypophosphatasia, and new advances in translational models using organoids. 📘🏛️ The SAEP General Assembly will also be held during the conference, featuring the presentation of results, voting, the awarding of diplomas and prizes, and the selection of the next host venue. You can view the detailed event program at the following 👉 link. This conference is a unique opportunity to update your knowledge, share experiences, build partnerships, and strengthen the pediatric endocrinology network in Andalusia. 🌱👩‍⚕️👨‍⚕️ If you’re a healthcare professional, researcher, or part of the pediatric and endocrinology fields, we encourage you to join this scientific conference. Your participation makes a difference and contributes to the advancement of the entire community.

🫀The Spanish Society of Family and Community Medicine (semFYC) has officially announced that the project “Differences in Blood Pressure Between Both Arms in Primary Care Patients with Vascular Risk,” presented by the INiBICA researcher CO15: Population and Health: Determinants and Interventions, 🧑‍⚕️ Dr. Manuel María Ortega Marlasca, has been awarded the 5th PAPPS/semFYC – Fundación Mutual Médica Research Prize in the 2025 call for proposals aimed at promoting research in preventive health 🔍 🤝 This recognition highlights the clinical relevance and potential impact of research conducted in primary care, as well as the commitment of Dr. Ortega Marlasca and his research group ( Team ) INVESTIGASUR to improving cardiovascular health and the early detection of vascular risk. 🌟 Our institution would like to extend our congratulations to Dr. Ortega Marlasca on this achievement and celebrate the value of initiatives that contribute to a more precise, effective, and patient-centered clinical practice 💙 🔗 More information: Instagram

📊 On November 27, INiBICA held a meeting at Cádiz with key non-scientific stakeholders, with the goal of incorporating their perspectives into the design and development of the 2026–2030 Strategic Plan (PE) and exploring future avenues for collaboration. 👨‍⚕️ Scientific Director Manuel Aguilar Diosdado , explained the importance of involving these organizations in the design of the Strategic Plan. The results of the previous Strategic Plan were presented, along with an explanation of how the new Strategic Plan had been designed to allow for their input prior to approval by the Governing Council. 🤝 The meeting brought together representatives from the Association of People with Myalgic Encephalomyelitis (PEM)—the NGO PEM, Salus Infirmorum, the Diabetes Cero Foundation, the Spanish Association for Lung Cancer Patients, Miramoon Pharma, and the Trébol de Corazones Heart Association, who shared their perspectives on society’s real needs and opportunities to strengthen knowledge transfer. 🎯 This initiative aims to ensure that INiBICA’s biomedical research is aligned with the region’s health and social challenges, fostering innovation and citizen participation. 🗣️ During the session, participants discussed proposals to improve science-society communication, promote collaborativ Projects s, and define strategic priorities that contribute to research that is more closely connected to society and has a direct impact on quality of life. 🔗 More information: Instagram

📍The School of Medicine at the University of Cádiz (UCA) has been chosen to host the 4th Annual Symposium of the Spanish Network for Adult Neurogenesis (RENA), held on November 27 and 28—a leading event that brings together researchers from across Spain to advance the science of neurogenesis, which is key to understanding neurodegenerative diseases such as Alzheimer’s, ALS, and Parkinson’s. 👩‍🔬We are proud to announce that Dr. Esther Berrocoso is playing a prominent role at INiBICA. Her involvement is yet another example of INiBICA’s commitment to cutting-edge research and scientific collaboration at the national level. 🌟 The symposium represents a unique opportunity to share knowledge, foster collaborations, and chart future research directions that could transform the treatment of neurological diseases. 🔬🤝 Congratulations to all the participants! 💙 And thank you to RENA, UCA, and INiBICA for making this scientific gathering possible at Cádiz. 🔗 More information: Instagram